ASC-话题@MedSci

#ASC#

1352篇内容 | 3905人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939002, encodeId=40dc193900299, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JACC：新胆固醇指南助力高危ASCVD患者的强化降脂治疗, objectType=article, longId=183084, objectId=57b71830841b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b71830841b, replyNumber=0, likeNumber=71, createdTime=2019-12-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b71830841b, moduleTitle=JACC：新胆固醇指南助力高危ASCVD患者的强化降脂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57b71830841b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939022, encodeId=014c19390226d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO-SITC：抗生素会降低黑色素瘤患者经免疫检查点抑制剂治疗的有效性, objectType=article, longId=187698, objectId=727018e69811, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=727018e69811, replyNumber=0, likeNumber=64, createdTime=2020-10-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=727018e69811, moduleTitle=2020年ASCO-SITC：抗生素会降低黑色素瘤患者经免疫检查点抑制剂治疗的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=727018e69811)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939038, encodeId=b43c1939038e5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=BMC Cardiovasc Disord：慢性心力衰竭和心房纤颤患者的β受体阻滞剂和全因死亡风险, objectType=article, longId=190417, objectId=8aca19041e2b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aca19041e2b, replyNumber=0, likeNumber=53, createdTime=2020-10-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aca19041e2b, moduleTitle=BMC Cardiovasc Disord：慢性心力衰竭和心房纤颤患者的β受体阻滞剂和全因死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aca19041e2b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939037, encodeId=3820193903ee3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle= Vasc Health Risk Manag：牙周炎与脑卒中密切相关, objectType=article, longId=189979, objectId=37e61899e9d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37e61899e9d8, replyNumber=0, likeNumber=52, createdTime=2020-10-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37e61899e9d8, moduleTitle= Vasc Health Risk Manag：牙周炎与脑卒中密切相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37e61899e9d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939045, encodeId=76e3193904551, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：11项中国研究入选口头报告，17项Poster报告, objectType=article, longId=193268, objectId=ea9f193268d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea9f193268d6, replyNumber=0, likeNumber=72, createdTime=2020-05-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea9f193268d6, moduleTitle=ASCO 2020：11项中国研究入选口头报告，17项Poster报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea9f193268d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939079, encodeId=ab5e19390e989, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 前沿 | CAR-T疗法治疗复发/难治性淋巴瘤重大突破汇总, objectType=article, longId=195239, objectId=015b195239ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=015b195239ca, replyNumber=0, likeNumber=91, createdTime=2020-09-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=015b195239ca, moduleTitle=ASCO 前沿 | CAR-T疗法治疗复发/难治性淋巴瘤重大突破汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=015b195239ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939003, encodeId=87cf193900361, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circulation：房颤持续时间和CHA2DS2-VASc评分对卒中风险的预测意义, objectType=article, longId=183093, objectId=0a1718309385, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a1718309385, replyNumber=0, likeNumber=75, createdTime=2020-02-27, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a1718309385, moduleTitle=Circulation：房颤持续时间和CHA2DS2-VASc评分对卒中风险的预测意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a1718309385)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939087, encodeId=b122193908eb1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO盛筵里的绕梁余音, objectType=article, longId=195621, objectId=4752195621f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4752195621f5, replyNumber=0, likeNumber=36, createdTime=2020-06-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4752195621f5, moduleTitle=ASCO盛筵里的绕梁余音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4752195621f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939007, encodeId=3c22193900ee5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=BMC Cardiovasc Disord :心衰患者要视烟草为大敌！中山大学附一院董吁钢等研究称：遇到二手烟，死亡风险增43%, objectType=article, longId=184267, objectId=f20e18426e96, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20e18426e96, replyNumber=0, likeNumber=82, createdTime=2020-10-13, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20e18426e96, moduleTitle=BMC Cardiovasc Disord :心衰患者要视烟草为大敌！中山大学附一院董吁钢等研究称：遇到二手烟，死亡风险增43%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f20e18426e96)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939009, encodeId=9fe6193900958, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JACC：PASCAL经导管瓣膜修复系统治疗严重三尖瓣返流的同情使用临床试验, objectType=article, longId=184899, objectId=06361848996e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06361848996e, replyNumber=0, likeNumber=72, createdTime=2020-05-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06361848996e, moduleTitle=JACC：PASCAL经导管瓣膜修复系统治疗严重三尖瓣返流的同情使用临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06361848996e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939072, encodeId=55a819390e241, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020 来了 | 前列腺癌领域重磅研究盘点, objectType=article, longId=195132, objectId=b8591951321a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8591951321a, replyNumber=0, likeNumber=86, createdTime=2021-02-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8591951321a, moduleTitle=ASCO 2020 来了 | 前列腺癌领域重磅研究盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8591951321a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939071, encodeId=e07519390e140, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, objectType=article, longId=195059, objectId=f74a195059c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f74a195059c2, replyNumber=0, likeNumber=82, createdTime=2020-06-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f74a195059c2, moduleTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f74a195059c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939069, encodeId=26251939069e7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：低免疫毒副作用的PD-L1抗体令人叹服, objectType=article, longId=195027, objectId=24f119502e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24f119502e0a, replyNumber=0, likeNumber=52, createdTime=2021-02-19, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24f119502e0a, moduleTitle=ASCO 2020：低免疫毒副作用的PD-L1抗体令人叹服, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24f119502e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939074, encodeId=362d19390e455, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO：三阴性乳腺癌（TNBC）部分靶向药研究进展汇总, objectType=article, longId=195134, objectId=a16e195134a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a16e195134a3, replyNumber=0, likeNumber=173, createdTime=2021-01-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a16e195134a3, moduleTitle=ASCO：三阴性乳腺癌（TNBC）部分靶向药研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a16e195134a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939040, encodeId=4c561939040b0, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=随着COVID-19大流行的继续，ASCO年会即将在线举行, objectType=article, longId=190828, objectId=3a87190828ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a87190828ed, replyNumber=0, likeNumber=70, createdTime=2020-11-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a87190828ed, moduleTitle=随着COVID-19大流行的继续，ASCO年会即将在线举行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a87190828ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939024, encodeId=4fc119390244d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果, objectType=article, longId=187728, objectId=50b618e7282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50b618e7282f, replyNumber=0, likeNumber=78, createdTime=2021-01-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50b618e7282f, moduleTitle=2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50b618e7282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939048, encodeId=40bc1939048ed, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JAMA Oncol：ASCO、ESMO会议上发布的阴性结果的临床试验，有多少没有如实报告？, objectType=article, longId=193344, objectId=f34c19334410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f34c19334410, replyNumber=0, likeNumber=76, createdTime=2021-01-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f34c19334410, moduleTitle=JAMA Oncol：ASCO、ESMO会议上发布的阴性结果的临床试验，有多少没有如实报告？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f34c19334410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939020, encodeId=adcd193902003, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO-SITC：头颈癌患者接受免疫治疗后，甲状腺功能减退的风险增加, objectType=article, longId=187676, objectId=852f18e67611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=852f18e67611, replyNumber=0, likeNumber=86, createdTime=2020-11-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=852f18e67611, moduleTitle=2020年ASCO-SITC：头颈癌患者接受免疫治疗后，甲状腺功能减退的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=852f18e67611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939010, encodeId=5b6119390106c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：利用30天连续动态监测识别TAVR后的迟发性房室传导阻滞, objectType=article, longId=185038, objectId=c4c718503805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4c718503805, replyNumber=0, likeNumber=65, createdTime=2020-11-05, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4c718503805, moduleTitle=Circ：Cardiovasc Inte：利用30天连续动态监测识别TAVR后的迟发性房室传导阻滞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4c718503805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939023, encodeId=604d19390234c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=187720, objectId=ddb118e72078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddb118e72078, replyNumber=0, likeNumber=74, createdTime=2020-03-04, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddb118e72078, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddb118e72078)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JACC：新胆固醇指南助力高危ASCVD患者的强化降脂治疗

2019-12-06

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO-SITC：抗生素会降低黑色素瘤患者经免疫检查点抑制剂治疗的有效性

2020-10-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

BMC Cardiovasc Disord：慢性心力衰竭和心房纤颤患者的β受体阻滞剂和全因死亡风险

2020-10-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Vasc Health Risk Manag：牙周炎与脑卒中密切相关

2020-10-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：11项中国研究入选口头报告，17项Poster报告

2020-05-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 前沿 | CAR-T疗法治疗复发/难治性淋巴瘤重大突破汇总

2020-09-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circulation：房颤持续时间和CHA2DS2-VASc评分对卒中风险的预测意义

2020-02-27

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO盛筵里的绕梁余音

2020-06-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

BMC Cardiovasc Disord :心衰患者要视烟草为大敌！中山大学附一院董吁钢等研究称：遇到二手烟，死亡风险增43%

2020-10-13

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JACC：PASCAL经导管瓣膜修复系统治疗严重三尖瓣返流的同情使用临床试验

2020-05-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020 来了 | 前列腺癌领域重磅研究盘点

2021-02-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值

2020-06-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：低免疫毒副作用的PD-L1抗体令人叹服

2021-02-19

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO：三阴性乳腺癌（TNBC）部分靶向药研究进展汇总

2021-01-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

随着COVID-19大流行的继续，ASCO年会即将在线举行

2020-11-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果

2021-01-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JAMA Oncol：ASCO、ESMO会议上发布的阴性结果的临床试验，有多少没有如实报告？

2021-01-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO-SITC：头颈癌患者接受免疫治疗后，甲状腺功能减退的风险增加

2020-11-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：利用30天连续动态监测识别TAVR后的迟发性房室传导阻滞

2020-11-05

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2020-03-04

科室
- - 订阅+
  - 更多科室
工具
服务